Development and validation of the method of quantitative determination of fluorine-containing drugs by the method of highly effective liquid chromatography


如何引用文章

全文:

开放存取 开放存取
受限制的访问 ##reader.subscriptionAccessGranted##
受限制的访问 订阅或者付费存取

详细

Objective. To develop and validate methods for the quantitative determination of fluorine-containing drugs in tablets by high performance liquid chromatography. Material and methods. In the work we used: pharmaceutical substance and tablets of linezolid, efavirenza and ofloxacin, which meet the requirements of regulatory documents. To develop methods for detecting and quantifying linezolid, efavirenz, and ofloxacin in tablets, a reverse-phase version of high-performance liquid chromatography in gradient elution was used, the conditions of which were selected experimentally. Optimal chromatographic conditions: column size - 75 x 2 mm, polymer sorbent - ProntoSil 120-5C AQ, mobile phase - Eluent A: 0.2 M LiClO4 - 0.005 M HClO4 (pH 2,8), Eluent B: Acetonitrile, gradient: 3700 pl from 5% to 70% eluent B, flow rate 100 pl / min, column temperature 40 ° C, sample volume 2 pl, wavelength 210 nm. Results. The conditions found were used to develop methods for the quantitative content of these substances in tablets. The retention times of ofloxacin were 15.39 minutes, linezolid 16.16 minutes and efavirenza 34.49 minutes. The relative error of the quantitative determination by the developed methods does not exceed 1.22% for ofloxacin, 1.08% for linezolid and 1.39% for efavirenz. Findings. During the study, unified methods were developed for the quantitative determination of fluorine-containing heterocyclic drugs - linezolid, efavirenz, and ofloxacin in tablets by high-performance liquid chromatography. A validation assessment of the developed methods was carried out. Thus, the developed methods make it possible to obtain sufficiently reliable and reproducible results for the intended field of application and can be recommended for pharmaceutical, chemical-toxicological, and forensic chemical analysis.

全文:

受限制的访问

作者简介

V. Tyutrina

Irkutsk State Medical University

Email: ultr4vox@yandex.ru
Post-graduate Student, Department of Pharmaceutical and Toxicological Chemistry

N. Chmelevskaya

Irkutsk Regional Bureau of Forensic Medicine

Ph.D. (Pharm.), Head of Head of the Department of Forensic Chemistry

E. Illarionova

Irkutsk State Medical University

Dr.Sc. (Chem.), Professor, Head of Department of Pharmaceutical and Toxicological Chemistry

参考

  1. Нормативный документ ФС 42-14653-00. Офлоксацин. М. 2000. 13 с.
  2. Нормативный документ ФС 42-12212-02. Офлоксацин, таблетки покрытые оболочкой 200 мг. М. 2002.19 с.
  3. Нормативный документ ФС 000704-120913. Линезолид. М. 2013. 17 с.
  4. Нормативный документ ФС 002276-111013. Линезолид, таблетки покрытые оболочкой 200 мг. М. 2013. 2 с.
  5. Нормативный документ ФС 000520-260313. Эфавиренз. М. 2013. 15 с.
  6. Amini M., Abdi Kh., Darabi M., Shafiee A. Determination of Ofloxacin in Plasma by HPLC with UV Detection. Journal of Applied Sciences. 2005; 5(9): 1655-1657. doi: 10.3923/jas.2005.1655.1657.
  7. Cios A., Kus K., Szymura-Oleksiak J. Determination of Line-zolid in Human Serum by Reversed-phase High-performance Liquid Chromatography with Ultraviolet and Diode Array Detection. Acta poloniae pharmaceutica. 2013; 70(4): 631-641.
  8. Hamrapurkar P., Phale M., Shah N. Quantitative Estimation of Efavirenz by High Performance Thin Layer Chromatography. Journal of Young Pharmacists. 2009; 1(4):369-373. D0I:10.4103/0975-1483.59328
  9. Государственная фармакопея Российской Федерации. XIII издание. МЗ РФ. М. 2015. Т. 1. 1470 c

补充文件

附件文件
动作
1. JATS XML

版权所有 © Russkiy Vrach Publishing House, 2019
##common.cookie##